HolmesGP, KaplanJE, GantzNM, et al.Chronic fatigue syndrome: A working case definition. Ann Intern Med, 1988; 108:387–389.
3.
Centers for Disease Control and Prevention. Chronic Fatigue Syndrome (CFS): General Information. Online document at: www.cdc.gov/cfs/general/index.html Accessed March5, 2015.
4.
MaesM. Inflammatory and oxidative and nitrosative stress cascades as new drug targets in myalgic encephalomyelitis and chronic fatigue syndrome. Mod Trends Pharmacopsychiatri, 2013; 28:162–174.
5.
Institute of Medicine of the National Academies. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): Key Facts. Online document at: www.iom.edu/∼/media/Files/Report%20Files/2015/MECFS/MECFS_KeyFacts.pdf Accessed March14, 2015.
6.
Centers for Disease Control and Prevention. Chronic Fatigue Syndrome (CFS) in Children and Adolescents. Online document at: www.cdc.gov/cfs/pediatric/index.html Accessed March9, 2015.
7.
Phoenix Rising. Hitting a Moving Target I: Defining and Quantifying CFS. The New Prevalence Estimates. Online document at: http://phoenixrising.me/research-2/defining-chronic-fatigue-syndrome-mecfs/hitting-a-moving-target-i-defining-and-quantifying-cfs-the-new-prevalence-estimates Accessed March10, 2015.
8.
JohnstoneS, BrenuEW, StainesD, Marshall-GradisnikS. The prevalence of chronic fatigue syndrome/myalgic encephalomyelitis: A meta-analysis. Clin Epidemiol, 2013; 5:105–110.
9.
FukudaK, StrausSE, HickieI, et al.The chronic fatigue syndrome: A comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann Intern Med, 1994; 121:953–959.
10.
BrurbergKG, FønhusMS, LarunL, et al.Case definitions for chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME): A systematic review. BMJ Open, 2014; 4:e003973.
11.
Institute of Medicine. Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Redefining an Illness. Online document at: www.iom.edu/∼/media/Files/Report%20Files/2015/MECFS/MECFS_ReportBrief.pdf Accessed March17, 2015.
12.
ElgenI, HikmatO, AspevikTN, HagenEM. CFS in children and adolescent [sic]: Ten years of retrospective clinical evaluation. Int J Pediatr, 2013; 2013:270373.
13.
LombardiVC, RuscettiFW, Das GuptaJ, et al.Detection of an infectious retrovirus, XMRV, in blood cells of patients with chronic fatigue syndrome. Science, 2009; 326:585–589.
14.
OakesB, TaiAK, CingözO, et al.Contamination of human DNA samples with mouse DNA can lead to false detection of XMRV-like sequences. Retrovirology, 2010; 7:109.
15.
RasaS, Nora-KruckleZ, ChapenkoS, et al.No evidence of XMRV provirus sequences in patients with myalgic encephalomyelitis/chronic fatigue syndrome and individuals with unspecified encephalopathy. New Microbiol, 2014; 37:17–24.
16.
JohnstonH. Chasing the Shadow Virus: Chronic Fatigue Syndrome and XMRV. Discover, March17, 2013. Online document at: http://discovermagazine.com/2013/march/17-shadow-virus Accessed March18, 2015.
17.
Martinez-MartinezLA, MoraT, VargasA, et al.Sympathetic nervous system dysfunction in fibromyalgia, chronic fatigue syndrome, irritable bowel syndrome, and interstitial cystitis: A review of case-control studies. J Clin Rheumatol, 2014; 20:146–150.
18.
MorrisG, MaesM. A neuro-immune model of myalgic encephalomyelitis/chronic fatigue syndrome. Metab Brain Dis, 2013; 28:523–540.
19.
MorrisG, BerkM, GaleckiP, et al.The neuro-immune pathophysiology of central and peripheral fatigue in systemic immune-inflammatory and neuro-immune diseases. Mol Neurobiol, 2015; January20:e-pub ahead of print.
20.
NijsJ, NeesA, PaulL, et al.Altered immune response to exercise in patients with chronic fatigue syndrome/myalgic encephalomyelitis: A systematic literature review. Exerc Immunol Rev, 2014; 20:94–116.
21.
HornigM, MontoyaJG, KlimasNG, et al.Distinct plasma immune signatures in ME/CFS are present early in the course of illness. Sci Adv, 2015; 1:e1400121.
22.
NakatomiY, MizunoK, IshiiA, et al.Neuroinflammation in patients with chronic fatigue syndrome/myalgic encephalomyelitis: An 11C-(R)-PK11195 PET study. J Nucl Med, 2014:55:945–950.
23.
ReynoldsGK, LewisDP, RichardsonAM, LidburyBA. Comorbidity of postural orthostatic tachycardia syndrome and chronic fatigue syndrome in an Australian cohort. J Intern Med, 2014; 275:409–417.
24.
Van CauwemberghD, NijsJ, KosD, et al.Malfunctioning of the autonomic nervous system in patients with chronic fatigue syndrome: A systematic literature review. Eur J Clin Invest, 2014; 44:516–526.
25.
KrzeczkowskaA, KaratziasT, DicksonA. Pain in people with chronic fatigue syndrome: The role of traumatic stress and coping strategies. Psychol Health Med, 2015; 20:210–216.
26.
StaudR, MokthechM, PriceDD, RobinsonME. Evidence for sensitized fatigue pathways in patients with chronic fatigue syndrome. Pain, 2015; 156:750–759.
27.
FurquimBD, FlamenguiLM, ContiPC. TMD and chronic pain: A current view. Dental Press J Orthod, 2015; 20:127–133.
OkaT, TanahashiT, ChijiwaT, et al.Isometric yoga improves the fatigue and pain of patients with chronic fatigue syndrome who are resistant to conventional therapy: A randomized, controlled trial. Biopsychosoc Med, 2014; 8:27.
30.
ChanJS, HoRT, ChungKF, et al.Qigong exercise alleviates fatigue, anxiety, and depressive symptoms, improves sleep quality, and shortens sleep latency in persons with chronic fatigue syndrome-like illness. Evid Based Complement Alternat Med, 2014; 2014:106048.
31.
MaricD, BrkicS, TomicS, et al.Multivitamin mineral supplementation in patients with chronic fatigue syndrome. Med Sci Monit, 2014; 20:47–53.
32.
TeitelbaumJE, JohnsonC, St CyrJ. The use of d-ribose in chronic fatigue syndrome and fibromyalgia: A pilot study. J Altern Complement Med, 2006; 12:857–862.
33.
VasiadiM, NewmanJ, TheoharidesTC. Isoflavones inhibit poly(I:C)-induced serum, brain, and skin inflammatory mediators—relevance to chronic fatigue syndrome. J Neuroinflammation, 2014; 11:168.
34.
BelcaroG, CornelliU, LuzziR, et al.Improved management of primary chronic fatigue syndrome with the supplement French oak wood extract (Robuvit®): A pilot, registry evaluation. Panminerva Med, 2014; 56:63–72.
35.
PorterNS, JasonLA, BoultonA, et al.Alternative medical interventions used in the treatment and management of myalgic encephalomyelitis/chronic fatigue syndrome and fibromyalgia. J Altern Complement Med, 2010; 16:235–249.
36.
AlraekT, LeeMS, ChoiTY, et al.Complementary and alternative medicine for patients with chronic fatigue syndrome: A systematic review. BMC Complement Altern Med, 2011; 11:87.
37.
WangYY, LiXX, LiuJP, et al.Traditional Chinese Medicine for chronic fatigue syndrome: A systematic review of randomized clinical trials. Complement Ther Med, 2014; 22:826–833.
38.
LeeJ-S, KimH-G, HanJ-M, et al.Ethanol extract of Astragali Radix and Salviae Miltiorrhizae Radix, Myelophil, exerts anti-amnesic effect in a mouse model of scopolamine-induced memory deficits. J Ethnopharmacol, 2014; 153:782–792.
39.
ChoJH, ChoCK, ShinJW, et al.Myelophil, an extract mix of Astragali Radix and Salviae Radix, ameliorates chronic fatigue: A randomised, double-blind, controlled pilot study. Complement Ther Med, 2009; 17:141–146.
40.
TeitelbaumJ. The Fatigue and Fibromyalgia Solution: The Essential Guide to Overcoming Chronic Fatigue and Fibromyalgia, Made Easy!. New York: Avery/Penguin Group, 2013.
41.
LoganAC, VenketRA, IraniD. Chronic fatigue syndrome: Lactic acid bacteria may be of therapeutic value. Med Hypotheses, 2003; 60:915–923.
42.
NaessH, NylandM, HauskenT, et al.Chronic fatigue syndrome after Giardia enteritis: Clinical characteristics, disability and long-term sickness absence. BMC Gastroenterol, 2012; 12:13.
43.
MyhillS, BoothNE, McLaren-HowardJ. Targeting mitochondrial dysfunction in the treatment of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)—a clinical audit. Int J Clin Exp Med, 2013; 6:1–15.
44.
MurphreeRH. Treating and Beating Fibromyalgia and Chronic Fatigue Syndrome: You Can Feel Good Again, 5th ed. Birmingham, AL: Harrison Hampton, 2013.
45.
Solve ME/CFS Initiative: Guest Blog: Dr. Lucinda Bateman on the Discussion Surrounding the IOM Report. Online document at: http://solvecfs.org/dr-bateman-discussion-post-iom-report/#at_pco+smlwn-1.0&at_si=54f8d50fe&at_ab=per-2&at_pos=0&at_tot=1 Accessed March28, 2015.